GCFRX
Price
$10.30
Change
+$0.01 (+0.10%)
Updated
Jun 2 closing price
Net Assets
237.33M
PIFIX
Price
$12.98
Change
+$0.02 (+0.15%)
Updated
Jun 2 closing price
Net Assets
2.18B
Interact to see
Advertisement

GCFRX vs PIFIX

Header iconGCFRX vs PIFIX Comparison
Open Charts GCFRX vs PIFIXBanner chart's image
GCFRX vs PIFIX Comparison Chart in %
View a ticker or compare two or three
VS
GCFRX vs. PIFIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCFRX is a StrongBuy and PIFIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PIFIX has more cash in the bank: 2.18B vs. GCFRX (237M). GCFRX (3.22) and PIFIX (3.13) have matching dividends . GCFRX was incepted earlier than PIFIX: GCFRX (23 years) vs PIFIX (19 years). GCFRX (1.21) is less costly to investors than PIFIX (0.73). GCFRX is a more actively managed with annual turnover of: 32.77 vs. PIFIX (23.90). GCFRX (0) and PIFIX (0) have matching initial minimum investment requirements. PIFIX annual gain was more profitable for investors over the last year : 10.06 vs. GCFRX (8.65). PIFIX return over 5 years is better than : 11.87 vs. GCFRX (7.77).
GCFRXPIFIXGCFRX / PIFIX
Total Expense Ratio1.210.73166%
Annual Report Gross Expense Ratio1.210.73166%
Fund Existence23 years19 years-
Gain YTD2.9193.43785%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets237M2.18B11%
Annual Yield % from dividends3.223.13103%
Returns for 1 year8.6510.0686%
Returns for 3 years17.9927.1566%
Returns for 5 years7.7711.8765%
Returns for 10 years27.6343.3264%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALL210.463.25
+1.57%
Allstate Corp (The)
GSHR10.40N/A
N/A
Gesher Acquisition Corporation II
MAIN51.57-0.04
-0.08%
Main Street Capital Corp
MLKN15.06-0.33
-2.11%
MillerKnoll
NCEL3.32-0.16
-4.60%
NewcelX Ltd.